Sphere Fluidics Overview
- Year Founded
-
2010
- Status
-
Private
- Employees
-
106
- Latest Deal Type
-
PE Growth
- (Upcoming)
- Latest Deal Amount
-
$37.1M
- Investors
-
20
Sphere Fluidics General Information
Description
Operator of a life sciences company intended to develop novel technologies for single-cell analysis, therapy development, and characterization. The company's cell analysis systems assist in the discovery of new cell strains and molecules and help scientists screen for and isolate rare and valuable biological variants across research, therapeutic, bioproduction, and diagnostic applications, enabling clients to reduce cost, and time and accelerate biological and biopharmaceutical discovery.
Contact Information
Website
www.spherebio.comCorporate Office
- Building One, Granta Centre
- Granta Park, Great Abington
- Cambridge CB21 6AL
- England, United Kingdom
Corporate Office
- Building One, Granta Centre
- Granta Park, Great Abington
- Cambridge CB21 6AL
- England, United Kingdom
Sphere Fluidics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 20. PE Growth/Expansion | $37.1M | Upcoming | Generating Revenue | |||
| 19. Later Stage VC | Completed | Generating Revenue | ||||
| 18. Later Stage VC | 28-Oct-2021 | Completed | Generating Revenue | |||
| 17. Secondary Transaction - Private | 01-May-2021 | Completed | Generating Revenue | |||
| 16. Debt - General | 30-Apr-2020 | Completed | Generating Revenue | |||
| 15. Later Stage VC | 10-Jun-2019 | Completed | Generating Revenue | |||
| 14. Debt - General | Completed | Generating Revenue | ||||
| 13. Grant | 27-Nov-2017 | Completed | Generating Revenue | |||
| 12. Grant | 17-Jul-2017 | $1.25M | $18.9M | Completed | Generating Revenue | |
| 11. Later Stage VC (Series C) | 31-Jan-2017 | $2.74M | $18.9M | Completed | Generating Revenue |
Sphere Fluidics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Ordinary | ||||||||
| Series A Preferred | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | ||||||||
| Ordinary | 2,303 | $0.013657 | $156.93 | $156.93 | 1x | $156.93 | 1.67% | |
| Ordinary | 4,062 | $0.013657 | $109.25 | $109.25 | 1x | $109.25 | 2.95% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Sphere Fluidics Comparisons
Industry
Financing
Details
Sphere Fluidics Competitors (32)
One of Sphere Fluidics’s 32 competitors is Abcam, a Corporate Backed or Acquired company based in Cambridge, United Kingdom.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Abcam | Corporate Backed or Acquired | Cambridge, United Kingdom | ||||
| ThinkCyte | Venture Capital-Backed | Tokyo, Japan | ||||
| HiFiBiO Therapeutics | Venture Capital-Backed | Cambridge, MA | ||||
| 4basebio | Corporation | Cambridge, United Kingdom | ||||
| Eurofins DiscoverX Products | Formerly VC-backed | Fremont, CA |
Sphere Fluidics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Sphere Fluidics Patents
Sphere Fluidics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| GB-202501068-D0 | Multiplexed analysis system | Pending | 24-Jan-2025 | ||
| GB-202412748-D0 | Droplet sorting and injection | Pending | 30-Aug-2024 | ||
| GB-202410396-D0 | Object detection system | Pending | 17-Jul-2024 | ||
| GB-202318206-D0 | Dendronized surfactants | Pending | 29-Nov-2023 | ||
| GB-2636109-A | Dendronized surfactants | Pending | 29-Nov-2023 | C11D1/008 |
Sphere Fluidics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Sphere Fluidics Investors (20)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Redmile Group | PE/Buyout | Minority | ||
| Sofinnova Partners | Venture Capital | Minority | ||
| Southern Angel Investors Club | Angel Group | Minority | ||
| Oxford Investment Consultants | Venture Capital | Minority | ||
| Angel (individual) | Minority |
Sphere Fluidics FAQs
-
When was Sphere Fluidics founded?
Sphere Fluidics was founded in 2010.
-
Where is Sphere Fluidics headquartered?
Sphere Fluidics is headquartered in Cambridge, United Kingdom.
-
What is the size of Sphere Fluidics?
Sphere Fluidics has 106 total employees.
-
What industry is Sphere Fluidics in?
Sphere Fluidics’s primary industry is Discovery Tools (Healthcare).
-
Is Sphere Fluidics a private or public company?
Sphere Fluidics is a Private company.
-
What is Sphere Fluidics’s current revenue?
The current revenue for Sphere Fluidics is .
-
How much funding has Sphere Fluidics raised over time?
Sphere Fluidics has raised $67.2M.
-
Who are Sphere Fluidics’s investors?
Redmile Group, Sofinnova Partners, Southern Angel Investors Club, Oxford Investment Consultants, and are 5 of 20 investors who have invested in Sphere Fluidics.
-
Who are Sphere Fluidics’s competitors?
Abcam, ThinkCyte, HiFiBiO Therapeutics, 4basebio, and Eurofins DiscoverX Products are some of the 32 competitors of Sphere Fluidics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
